Tag: Janssen

J&J Sues Biden Administration to Block Medicare Drug Price Negotiations

July 19, 2023
Business & MarketsCompaniescongressDemocratsdrug priceseconomic policieseconomyExecutive BranchHealth and Human ServicesInflation Reduction ActInvestmentJanssenJohnson JohnsonJudiciaryMarketsMedicarePolicies & ImpactsPoliticsUSUS News
0 Comment

Johnson & Johnson sued to stop the U.S. government from empowering Health and Human Services (HHS) to negotiate lower drug prices for Medicare recipients. The major drugmaker became the third player in the industry attempting to halt the Medicare drug-price negotiations established by the Inflation Reduction Act (IRA), in a claim filed in the U.S. District…

Read More

EU Regulator Finds ‘Possible Link’ Between J&J Vaccine and Blood Clots

April 20, 2021
Astrazenecablood clotsCCP VirusCOVID-19EuropeEuropean Medicines AgencyEuropean UnionJanssenVaccineVaccines & SafetyWorld
0 Comment

The European Union’s medicines regulator said on Tuesday that there is a “possible link” between Johnson & Johnson’s COVID-19 vaccine and blood clots, but said its “overall benefit-risk remains positive.” At a meeting on Tuesday, the safety committee of the European Medicines Agency (EMA) concluded that a warning about unusual blood clots should be added…

Read More

Single-Shot Janssen COVID-19 Vaccine ‘Very Encouraging’: Boris Johnson

January 29, 2021
Boris JohnsonCCP VirusCOVID-19EuropeJanssenUKUSVaccineWorld
0 Comment

Clinical trials showing the single-shot Janssen vaccine as being 66 percent effective at preventing the COVID-19 disease are “very encouraging,” British Prime Minister Boris Johnson said on Friday. “We have secured 30 million doses, and if approved by our medicines regulator we should expect these to be available later this year,” he wrote on Twitter. Janssen…

Read More